Similar articles

• [A new future for beta blockers: metoprolol reduces mortality and the need for heart transplantation in patients with dilated cardiomyopathy].

  [No authors listed] [No authors listed] Minerva Cardioangiol. 1992 Dec;40(12):IX-X. Minerva Cardioangiol. 1992. PMID: 1296151 Clinical Trial. Italian. No abstract available.
• Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome.

  De Maria R, Di Lenarda A, Gavazzi A, Porcu M, Sinagra G, Parolini M; SPIC (Italian Multicenter Cardiomyopathy Study) Group. De Maria R, et al. Ital Heart J. 2001 Feb;2(2):130-8. Ital Heart J. 2001. PMID: 11256541
• 3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial. The Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.

  [No authors listed] [No authors listed] Lancet. 1998 Apr 18;351(9110):1180-1. Lancet. 1998. PMID: 9643698 Clinical Trial. No abstract available.
• Predictive value of heart rate in dilated cardiomyopathy treated with metoprolol.

  Perkan A, Di Lenarda A, Sinagra G, Gregori D, Cherubini A, Zecchin M, Gortan R, Klugmann S, Camerini F. Perkan A, et al. G Ital Cardiol. 1997 Nov;27(11):1106-12. G Ital Cardiol. 1997. PMID: 9419820
• [Adrenergic beta receptor blockaders in congestive heart failure: potential mechanisms of their action].

  Ruth-Maurin A, Bilińska ZT. Ruth-Maurin A, et al. Kardiol Pol. 1988;31(6):391-401. Kardiol Pol. 1988. PMID: 2853243 Review. Polish. No abstract available.